BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14514380)

  • 1. [Comparison of the Epstein-Barr virus infection and 30 bp-deleted LMP1 gene among 4 histologic types of nasopharyngeal carcinoma].
    Zhang M; Zong YS; He JH; Zhong BL; Lin SX; Liang YJ
    Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):342-6. PubMed ID: 14514380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of sequence variations of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma].
    Lin SX; Zong YS; Zhang M; Han AJ; Zhong BL; Liang YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):791-5. PubMed ID: 16545188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of Epstein-Barr virus with BamHI "f" variant and XhoI-loss of LMP1 gene in nasopharyngeal carcinoma].
    Han AJ; Zong YS; Zhang M; Cao SM; Lin SX; Liang YJ
    Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):534-8. PubMed ID: 14761599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of an XhoI-site within N-terminal region of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma.
    Lin SX; Zong YS; Wu QL; Han AJ; Liang YJ
    Ai Zheng; 2003 Nov; 22(11):1147-51. PubMed ID: 14613641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
    Tiwawech D; Srivatanakul P; Karalak A; Ishida T
    J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea.
    Jeon YK; Lee BY; Kim JE; Lee SS; Kim CW
    Head Neck; 2004 Jul; 26(7):573-83. PubMed ID: 15229899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary adenoid cystic carcinoma of the nasopharynx and its relation to Epstein-Barr virus infection].
    He JH; Zong YS; Zhang M; Zhong BL; Liang YJ; Liang XM
    Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):234-7. PubMed ID: 12882689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
    Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal.
    Neves M; Marinho-Dias J; Ribeiro J; Esteves M; Maltez E; Baldaque I; Breda E; Monteiro E; Medeiros R; Sousa H
    J Med Virol; 2015 Aug; 87(8):1382-8. PubMed ID: 25879824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population.
    Wanvimonsuk S; Thitiwanichpiwong P; Keelawat S; Mutirangura A; Kitkumthorn N
    J Med Virol; 2019 Mar; 91(3):444-449. PubMed ID: 30229949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
    Murono S; Yoshizaki T; Park CS; Furukawa M
    Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients.
    Hadhri-Guiga B; Khabir AM; Mokdad-Gargouri R; Ghorbel AM; Drira M; Daoud J; Frikha M; Jlidi R; Gargouri A
    Virus Res; 2006 Jan; 115(1):24-30. PubMed ID: 16154221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
    Feng YF; Wu QL; Zong YS
    Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.
    See HS; Yap YY; Yip WK; Seow HF
    World J Surg Oncol; 2008 Feb; 6():18. PubMed ID: 18275617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
    Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
    Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
    Liu JR; Lin Q; Wu XY
    Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction.
    Murono S; Yoshizaki T; Tanaka S; Takeshita H; Park CS; Furukawa M
    Laryngoscope; 1997 Apr; 107(4):523-6. PubMed ID: 9111384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies.
    da Costa VG; Marques-Silva AC; Moreli ML
    Syst Rev; 2015 Apr; 4():46. PubMed ID: 25927427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.